|21.30||-0.18 / -0.84%|
As of 3:59pm ET
|21.23||-0.0694 / -0.33%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 36.00 and a low estimate of 25.00. The median estimate represents a +31.46% increase from the last price of 21.30.
The current consensus among 5 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.